El narco-régimen criminal de Maduro ha violado repetidamente el acuerdo de Barbados, todo mientras continúa socavando a la principal líder opositora de Venezuela, María Corina Machado. Actualmente, varios miembros del equipo de campaña de Machado permanecen detenidos...
News
Latest News
Rubio, Risch on Biden Administration’s Decision Not to Extend Oil License to Criminal Maduro Regime
The criminal Maduro narco-regime has repeatedly violated the Barbados agreement as it continues to undermine the leading Venezuelan opposition leader, María Corina Machado. Currently, several members of Machado’s campaign team remain arbitrarily detained. Every action...
Rubio Praises Graham’s Service
U.S. Senator Marco Rubio (R-FL) released a statement following the death of former Florida Governor and U.S. Senator Bob Graham. “Bob Graham was a selfless public servant, whose legacy and impact will live on. From his days in the state House to his days in the...
Rubio: Investigate Shein and Temu for Slave Labor
Fast fashion retailer, Shein, and e-commerce company, Temu, have exploded in popularity despite evidence that both companies are exporting goods to the United States made with Uyghur slave labor. U.S. Senator Marco Rubio’s (R-FL) Uyghur Forced Labor...
Rubio y Kaine Aplauden Aprobación del Comité de Relaciones Exteriores de su Legislación para Imponer Sanciones a Nicaragua
Durante una reunión del Comité de Relaciones Exteriores, la Ley de Restauración de la Soberanía y los Derechos Humanos en Nicaragua, de autoría de los senadores estadounidenses Marco Rubio (R-FL) y Tim Kaine (D-VA), pasó favorablemente. El proyecto de ley bipartidista...
Rubio, Kaine Applaud Committee Passage of Nicaragua Sanctions Bill
During a Senate Committee on Foreign Relations business meeting, the Restoring Sovereignty and Human Rights in Nicaragua Act, co-led by U.S. Senators Marco Rubio (R-FL) and Tim Kaine (D-VA), was favorably reported. The bipartisan and bicameral bill now heads to the...
ICYMI: Rubio: China is Targeting America’s Biomed Industry
China is targeting America’s biomed industry
By U.S. Senator Marco Rubio
September 21, 2019
Modern Healthcare
Time after time, Americans have watched our nation’s leaders—in politics, academia and the private sector—invest in and open our markets to China with little concern for long-term consequences. When it comes to the threat China poses to the U.S. healthcare industry, we cannot afford to be complacent.
While consumers may have initially welcomed the influx of inexpensive Chinese goods, such as generic drugs and antibiotics, the ultimate price is paid by U.S. manufacturers, who are undercut by China’s cheap labor and forced to shutter. Beijing will continue to undermine America’s withering industries by blatantly stealing our companies’ intellectual property and subsidizing state firms to undercut our competitive edge. China’s goal is market dominance.
…
If we fail to prevent Chinese genomic dominance, how might the future look? Our dependence on Beijing for antibiotics and other drugs, recently flagged by the Pentagon, is instructive. The Chinese have used their command in the pharmaceutical industry as a bargaining chip in tariff negotiations. As the sole makers of some of our military’s drugs, they wield an additional source of leverage in the case of future conflict.
If you find yourself in a hole, the first step is to stop digging. We must immediately enact stricter guidelines for federal policies to guarantee that public funding never contributes to Chinese genomics efforts and then ensure our R&D in this critical area is not eclipsed by China. I have written to HHS’ OIG to voice concerns and submitted several National Defense Authorization Act amendments to this end. I am also developing a unified strategy to protect Americans’ genomic data. Beijing blocks its citizens’ DNA from being shared or stored outside China because they know the data’s value. Why don’t we consider similar measures to prevent others from benefiting from Americans’ DNA?
Chinese domination of the genomics industry poses an extraordinary danger to Americans; medical professionals, healthcare executives and policymakers alike must recognize the extent of the threat. Failure to do so will put our nation’s well-being at risk.
Read more here.